They’re designed to kill cancer cells, and they kill themselves in the process.
Researchers say a combination of new treatments can stop the world's deadliest form of skin cancer—melanoma.
A Food and Drug Administration panel has recommended approval of a leukemia treatment that rewires a patient’s immune cells to fight cancer.
A first-of-its-kind nanoparticle vaccine immunotherapy has been developed that targets several different cancer types
A chemical found in tumors may help stop tumor growth, according to a new study.
Two infants diagnosed with an aggressive and previously incurable form of leukemia are now in remission, after British doctors say they cured the babies using so-called "designer cells".
The CRISPR-Cas9 gene editing technique has been used in its first human trial. Scientists at Sichuan University in Chengdu, China began a trial last month to treat a lung cancer patient.
It's happening: as early as later this year, the gene-editing power tool CRISPR could be used in its first ever human trial.
Researchers believe they have beaten the “Death Star” of cancer with a new method of treatment involving nanotechnology.
The last few years has seen a massive leap in terms of genome editing. With the development of the incredible CRISPR/Cas9 technique, never before have scientists been able to so easily and precisely identify, edit, or remove specific sections of DNA.
Drug-resistant leukemia cells absorb a drug and die, when the drug is hidden inside a capsule made of folded up DNA.
An international team of researchers has seen "extraordinary" results using patients' own immune cells to fight cancer. In one trial, 94 percent of patients with acute lymphoblastic leukaemia saw their symptoms disappear entirely.
